Scientists at Tomsk Polytechnic University (TPU) have made a breakthrough in the field of nanotechnology - they have developed unique magnetic nanoparticles capable of controlling cell activity using a magnetic field. This discovery could become the basis for creating new treatments in oncology and regenerative medicine.
The researchers created functionalized magnetoelectric nanoparticles (capable of responding to a magnetic field) with a "core-shell" structure based on biocompatible materials (that do not cause rejection by the body). Their size is ten times smaller than existing analogues, and most importantly, they are able to both activate and suppress cellular processes on command.
The developed nanoparticles with citric acid and pectin have significantly different surface potentials, but at the same time have an identically strong magnetoelectric response, which is comparable to potentially more toxic foreign analogues. This opens up new horizons for controlling cellular activity.
Nanoparticles are unique devices that can operate in two modes. When exposed to a magnetic field, they stimulate the growth of healthy cells, and in another mode, they suppress the activity of malignant cells. This happens without surgical intervention, which makes them especially attractive for the treatment of various diseases.
The particles themselves are ten times smaller than their predecessors and have improved magnetoelectric properties, which makes them more effective in solving complex problems.
One of the important advantages of the development is that the surface treatment of nanoparticles with biocompatible compounds did not change their basic properties. This ensures high accuracy of delivery and wireless electrostimulation of cells and tissues.
We have succeeded in demonstrating control over cellular activity using magnetoelectric nanoparticles. We can stimulate the growth of healthy cells and suppress the activity of malignant cells. In the future, this approach could radically change approaches to cancer therapy and regenerative medicine.
Scientists from several leading scientific centers in Russia took part in the study, including the Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, the G.K. Boreskov Institute of Catalysis, and the Vladimir Zelman Center for Neurobiology and Neurorehabilitation.
The results of the study are published in the authoritative journal ACS Applied Materials & Interfaces, which confirms the high scientific level of the development. The project received support from the Russian Science Foundation.
Read more materials on the topic:
Chromizing zirconium will make work at nuclear power plants safer
Now on home
Publication about support for data extraction in forensic software called a fake
Flights added amid a 197% increase in Russian tourist flow to Vietnam over the year
Banks and MFIs will transmit data to credit bureaus, and they, in turn, will send information to the borrower's personal account
The vehicle was tested on real city routes in Siberian frosts
The rifle maintains accuracy at −20°C and is used with domestic .22LR cartridges
Sales of MP3 players are also growing: turnover increased by 25% in January - March, average check - by 13%
The Institute of Gastronomy of SFU and the brand chef of Bellini will create original food for astronauts for the 65th anniversary of Gagarin's flight
G2-G3 class storms are expected as early as tomorrow
"Russian Space Systems" Presented the Results of the First Years of the Decade of Science at the "Archimedes-2026" Exhibition
The umbrella brand will include Largus vans, an all-terrain vehicle based on the Niva, special vehicles from Promtekh, and methane versions of Largus and Vesta
Industrial partner - Avtodom, all components from polyurethane foam to heating elements - Russian